Cited by 386Liver Disease Diagnosis and TreatmentLiver physiology and pathologyLiver Diseases and Immunity

The DOI matches its Crossref record; 135 of the 137 references it cites were found in a registry or an index.

Adaptive immunity: an emerging player in the progression of NAFLD

Open access

Sutti, Salvatore, Albano, Emanuele·2020·Nature Reviews Gastroenterology & Hepatology

DOI 10.1038/s41575-019-0210-2PMC PMC7222953

Open this paper in CoChat — free account Open PDF

Abstract

In the past decade, nonalcoholic fatty liver disease (NAFLD) has become a leading cause of chronic liver disease and cirrhosis, as well as an important risk factor for hepatocellular carcinoma (HCC). NAFLD encompasses a spectrum of liver lesions, including simple steatosis, steatohepatitis and fibrosis. Although steatosis is often harmless, the lobular inflammation that characterizes nonalcoholic steatohepatitis (NASH) is considered a driving force in the progression of NAFLD. The current view is that innate immune mechanisms represent a key element in supporting hepatic inflammation in NASH. However, increasing evidence points to the role of adaptive immunity as an additional factor promoting liver inflammation. This Review discusses data regarding the role of B cells and T cells in sustaining the progression of NASH to fibrosis and HCC, along with the findings that antigens originating from oxidative stress act as a trigger for immune responses. We also highlight the mechanisms affecting liver immune tolerance in the setting of steatohepatitis that favour lymphocyte activation. Finally, we analyse emerging evidence concerning the possible application of immune modulating treatments in NASH therapy.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/s41575-019-0210-2

Cites

135 of 135 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
Younossi, Z., Anstee, Q. M., Marietti, M., Hardy, T., Henry, L., Eslam, M., George, J., & Bugianesi, E. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.109 · Cited by 5,249
Mechanisms of NAFLD development and therapeutic strategies
Friedman, S. L., Neuschwander-Tetri, B. A., Rinella, M., & Sanyal, A. J. (2018) · Nature Medicine · doi:10.1038/s41591-018-0104-9 · Cited by 4,354
Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis
Tilg, H., & Moschen, A. R. (2010) · Hepatology · doi:10.1002/hep.24001 · Cited by 2,548
Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity
Henao-Mejia, J., Elinav, E., Jin, C., Hao, L., Mehal, W. Z., Strowig, T., Thaiss, C. A., Kau, A. L., Eisenbarth, S. C., Jurczak, M. J., et al. (2012) · Nature · doi:10.1038/nature10809 · Cited by 2,435
Nonalcoholic Fatty Liver Disease
Rinella, M. E. (2015) · JAMA · doi:10.1001/jama.2015.5370 · Cited by 2,320
Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030
Estes, C., Anstee, Q. M., Arias, M., Bantel, H., Bellentani, S., Caballería, J., Colombo, M., Craxì, A., Crespo, J., Day, C. P., et al. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.05.036 · Cited by 2,046
Dietary and Genetic Obesity Promote Liver Inflammation and Tumorigenesis by Enhancing IL-6 and TNF Expression
Park, E. J., Lee, J. H., Yu, G.-Y., He, G., Ali, S. R., Holzer, R. G., Österreicher, C. H., Takahashi, H., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2009.12.052 · Cited by 1,764
Immunology in the liver — from homeostasis to disease
Heymann, F., & Tacke, F. (2016) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2015.200 · Cited by 1,180
Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: The central role of nontriglyceride fatty acid metabolites†
Neuschwander‐Tetri, B. A. (2010) · Hepatology · doi:10.1002/hep.23719 · Cited by 1,077
The immunology of hepatocellular carcinoma
Ringelhan, M., Pfister, D., O’Connor, T., Pikarsky, E., & Heikenwalder, M. (2018) · Nature Immunology · doi:10.1038/s41590-018-0044-z · Cited by 1,076
Targeting hepatic macrophages to treat liver diseases
Tacke, F. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.02.026 · Cited by 1,003
Endoplasmic reticulum stress signalling and the pathogenesis of non-alcoholic fatty liver disease
Lebeaupin, C., Vallée, D., Hazari, Y., Hetz, C. A., Chevet, É., & Bailly‐Maitre, B. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.06.008 · Cited by 971
Hepatocellular carcinoma in non-alcoholic fatty liver disease: An emerging menace
Baffy, G., Brunt, E. M., & Caldwell, S. H. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.10.027 · Cited by 872
Antigen-presenting cell function in the tolerogenic liver environment
Thomson, A. W., & Knolle, P. A. (2010) · Nature reviews. Immunology · doi:10.1038/nri2858 · Cited by 830
NAFLD causes selective CD4+ T lymphocyte loss and promotes hepatocarcinogenesis
Ma, C., Kesarwala, A. H., Eggert, T., Medina-Echeverz, J., Kleiner, D. E., Jin, P., Stroncek, D. F., Terabe, M., Kapoor, V., ElGindi, M., et al. (2016) · Nature · doi:10.1038/nature16969 · Cited by 766
Ectopic lymphoid-like structures in infection, cancer and autoimmunity
Pitzalis, C., Jones, G. W., Bombardieri, M., & Jones, S. A. (2014) · Nature reviews. Immunology · doi:10.1038/nri3700 · Cited by 715
Metabolic Activation of Intrahepatic CD8+ T Cells and NKT Cells Causes Nonalcoholic Steatohepatitis and Liver Cancer via Cross-Talk with Hepatocytes
Wolf, M. J., Adili, A., Piotrowitz, K., Abdullah, Z., Boege, Y., Stemmer, K., Ringelhan, M., Simonavicius, N., Egger, M., Wohlleber, D., et al. (2014) · Cancer Cell · doi:10.1016/j.ccell.2014.09.003 · Cited by 678
A randomized, placebo-controlled trial of cenicriviroc for treatment of nonalcoholic steatohepatitis with fibrosis
Friedman, S. L., Ratziu, V., Harrison, S. A., Abdelmalek, M. F., Aithal, G. P., Caballeria, J., Francque, S., Farrell, G., Kowdley, K. V., Craxi, A., et al. (2018) · Hepatology · doi:10.1002/hep.29477 · Cited by 671
The ST2/IL-33 Axis in Immune Cells during Inflammatory Diseases
Griesenauer, B., & Paczesny, S. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00475 · Cited by 641
Extrahepatic complications of nonalcoholic fatty liver disease
Armstrong, M. J., Adams, L. A., Canbay, A. E., & Syn, W. (2013) · Hepatology · doi:10.1002/hep.26717 · Cited by 617
Non-invasive assessment of non-alcoholic fatty liver disease: Clinical prediction rules and blood-based biomarkers
Gómez, E. V., & Chalasani, N. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.11.013 · Cited by 608
Inflammasome activation and function in liver disease
Szabó, G., & Petrasek, J. (2015) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2015.94 · Cited by 600
Non-alcoholic fatty liver disease and cardiovascular risk: Pathophysiological mechanisms and implications
Francque, S., van der Graaff, D., & Kwanten, W. J. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.04.005 · Cited by 591
Inflammation-induced IgA+ cells dismantle anti-liver cancer immunity
Shalapour, S., Lin, X.-J., Bastian, I. N., Brain, J., Burt, A. D., Aksenov, A. A., Vrbanac, A. F., Li, W., Perkins, A., Matsutani, T., et al. (2017) · Nature · doi:10.1038/nature24302 · Cited by 589
Oral tolerance
Weiner, H. L., da Cunha, A. P., Quintana, F. J., & Wu, H. D. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01017.x · Cited by 561
Cytokine-producing B lymphocytes-key regulators of immunity
Lund, F. E. (2008) · Current Opinion in Immunology · doi:10.1016/j.coi.2008.03.003 · Cited by 556
ER Stress Cooperates with Hypernutrition to Trigger TNF-Dependent Spontaneous HCC Development
Nakagawa, H., Umemura, A., Taniguchi, K., Font-Burgada, J., Dhar, D., Ogata, H., Zhong, Z., Valasek, M. A., Seki, E., Hidalgo, J., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.07.001 · Cited by 525
The Role of Cholesterol in the Pathogenesis of NASH
Ioannou, G. N. (2016) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2015.11.008 · Cited by 498
Determinants of Fibrosis Progression and Regression in NASH
Schuppan, D., Surabattula, R., & Wang, X. Y. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2017.11.012 · Cited by 479
Role of innate and adaptive immunity in obesity-associated metabolic disease
McLaughlin, T., Ackerman, S. E., Shen, L., & Engleman, E. G. (2017) · Journal of Clinical Investigation · doi:10.1172/jci88876 · Cited by 462
Oral tolerance.
Weiner, H. L. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.23.10762 · Cited by 455
The portal inflammatory infiltrate and ductular reaction in human nonalcoholic fatty liver disease
Gadd, V. L., Skoien, R., Powell, E. E., Fagan, K. J., Winterford, C., Horsfall, L., Irvine, K., & Clouston, A. D. (2014) · Hepatology · doi:10.1002/hep.26937 · Cited by 452
Current and upcoming pharmacotherapy for non-alcoholic fatty liver disease
Rotman, Y., & Sanyal, A. J. (2016) · Gut · doi:10.1136/gutjnl-2016-312431 · Cited by 420
Liver inflammation abrogates immunological tolerance induced by Kupffer cells
Heymann, F., Peusquens, J., Ludwig‐Portugall, I., Kohlhepp, M. S., Ergen, C., Niemietz, P. M., Martin, C., van Rooijen, N., Ochando, J., Randolph, G. J., et al. (2015) · Hepatology · doi:10.1002/hep.27793 · Cited by 415
Obesity, Fat Mass and Immune System: Role for Leptin
Francisco, V., Pino, J., Campos-Cabaleiro, V., Ruiz-Fernández, C., Mera, A., Gonzalez-Gay, M. A., Gómez, R., & Gualillo, O. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00640 · Cited by 411
Metabolic Inflammation-Associated IL-17A Causes Non-alcoholic Steatohepatitis and Hepatocellular Carcinoma
Gomes, A. L., Teijeiro, A., Burén, S., Tummala, K. S., Yilmaz, M., Waisman, A., Theurillat, J.-P., Perna, C., & Djouder, N. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.05.020 · Cited by 401
Obesity Drives STAT-1-Dependent NASH and STAT-3-Dependent HCC
Grohmann, M., Wiede, F., Dodd, G. T., Gurzov, E. N., Ooi, G. J., Butt, T., Rasmiena, A. A., Kaur, S., Gulati, T., Goh, P. K., et al. (2018) · Cell · doi:10.1016/j.cell.2018.09.053 · Cited by 373
Oxidative stress in autoimmune rheumatic diseases
Smallwood, M. J., Nissim, A., Knight, A. R., Whiteman, M., Haigh, R. C., & Winyard, P. G. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.05.086 · Cited by 358
Pathological Features of Fatty Liver Disease
Yeh, M. M., & Brunt, E. M. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.07.056 · Cited by 352
Fecal SCFAs and SCFA-producing bacteria in gut microbiome of human NAFLD as a putative link to systemic T-cell activation and advanced disease
Rau, M., Rehman, A., Dittrich, M., Groen, A. K., Hermanns, H. M., Seyfried, F., Beyersdorf, N., Dandekar, T., Rosenstiel, P., & Geier, A. (2018) · United European Gastroenterology Journal · doi:10.1177/2050640618804444 · Cited by 334
Induction of regulatory T cells decreases adipose inflammation and alleviates insulin resistance in ob/ob mice
Ilan, Y., Maron, R., Tukpah, A.-M. C., Maioli, T. U., Murugaiyan, G., Yang, K., Wu, H. Y., & Weiner, H. L. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908771107 · Cited by 327
Immunity, tolerance and autoimmunity in the liver: A comprehensive review
Doherty, D. G. (2015) · Journal of Autoimmunity · doi:10.1016/j.jaut.2015.08.020 · Cited by 322
Progression from Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis Is Marked by a Higher Frequency of Th17 Cells in the Liver and an Increased Th17/Resting Regulatory T Cell Ratio in Peripheral Blood and in the Liver
Rau, M., Schilling, A.-K., Meertens, J., Hering, I., Weiss, J., Jurowich, C., Kudlich, T., Hermanns, H. M., Bantel, H., Beyersdorf, N., et al. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1501175 · Cited by 302
Inflammatory dendritic cells in mice and humans
Segura, É., & Amigorena, S. (2013) · Trends in Immunology · doi:10.1016/j.it.2013.06.001 · Cited by 301
Dietary Factors Alter Hepatic Innate Immune System in Mice With Nonalcoholic Ratty Liver Disease * #
Li, Z., Soloski, M. J., & Diehl, A. M. (2005) · Hepatology · doi:10.1002/hep.20826 · Cited by 300
Modulation of liver tolerance by conventional and nonconventional antigen-presenting cells and regulatory immune cells
Horst, A. K., Neumann, K., Diehl, L., & Tiegs, G. (2016) · Cellular & Molecular Immunology · doi:10.1038/cmi.2015.112 · Cited by 295
Interleukin-17 exacerbates hepatic steatosis and inflammation in non-alcoholic fatty liver disease
Tang, Y., Bian, Z., Zhao, L., Liu, Y., Liang, S., Wang, Q., Han, X., Peng, Y., Chen, X., Shen, L., et al. (2011) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2011.04471.x · Cited by 294
Immune tolerance in liver disease
Crispe, I. N. (2014) · Hepatology · doi:10.1002/hep.27254 · Cited by 289
Attenuated liver fibrosis in the absence of B cells
Novobrantseva, T. I. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24798 · Cited by 277
Adaptive immune responses triggered by oxidative stress contribute to hepatic inflammation in NASH
Sutti, S., Jindal, A., Locatelli, I., Vacchiano, M., Gigliotti, L., Bozzola, C., & Albano, E. (2014) · Hepatology · doi:10.1002/hep.26749 · Cited by 270
Self-citation
Adaptive Response of T and B Cells in Atherosclerosis
Ketelhuth, D. F. J., & Hansson, G. K. (2016) · Circulation Research · doi:10.1161/circresaha.115.306427 · Cited by 269
Chemokine receptor CXCR6-dependent hepatic NK T Cell accumulation promotes inflammation and liver fibrosis
Wehr, A., Baeck, C., Heymann, F., Niemietz, P. M., Hammerich, L., Martin, C., Zimmermann, H. W., Pack, O., Gassler, N., Hittatiya, K., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202909 · Cited by 268
NKT-Associated Hedgehog and Osteopontin Drive Fibrogenesis in Non-Alcoholic Fatty Liver Disease
Syn, W.-K., Agboola, K. M., Swiderska, M., Michelotti, G. A., Liaskou, E., Pang, H., Xie, G., Philips, G., Chan, I. S., Karaca, G. F., et al. (2012) · Gut · doi:10.1136/gutjnl-2011-301857 · Cited by 266
IL-17 Signaling Accelerates the Progression of Nonalcoholic Fatty Liver Disease in Mice
Harley, I. T. W., Stankiewicz, T. E., Giles, D. A., Softic, S., Flick, L. M., Cappelletti, M., Sheridan, R. M., Xanthakos, S. A., Steinbrecher, K. A., Sartor, R. B., et al. (2013) · Hepatology · doi:10.1002/hep.26746 · Cited by 257
Non-alcoholic fatty liver and the gut microbiota
Bashiardes, S., Shapiro, H., Rozin, S., Shibolet, O., & Elinav, E. (2016) · Molecular Metabolism · doi:10.1016/j.molmet.2016.06.003 · Cited by 241
The Natural History of Nonalcoholic Fatty Liver Disease - An Evolving View
Lindenmeyer, C. C., & Mccullough, A. (2018) · Clinical Liver Disease · doi:10.1016/j.cld.2017.08.003 · Cited by 240
The microbiome and autoimmunity: a paradigm from the gut–liver axis
Li, B., Selmi, C. F., Tang, R., Gershwin, M. E., & Ma, X. (2018) · Cellular and Molecular Immunology · doi:10.1038/cmi.2018.7 · Cited by 237
Mucosal-associated invariant T cells are a profibrogenic immune cell population in the liver
Hegde, P., Weiss, E., Paradis, V., Wan, J., Mabire, M., Sukriti, S., Rautou, P.-E., Albuquerque, M., Picq, O., Gupta, A. C., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04450-y · Cited by 232
Targeting BAFF and APRIL in systemic lupus erythematosus and other antibody-associated diseases
Samy, E. T., Wax, S. D., Huard, B., Hess, H., & Schneider, P. (2017) · International Reviews of Immunology · doi:10.1080/08830185.2016.1276903 · Cited by 222
Immune response towards lipid peroxidation products as a predictor of progression of non‐alcoholic fatty liver disease to advanced fibrosis
Albano, E., Mottaran, E., Vidali, M., Reale, E., Saksena, S., Occhino, G., Burt, A. D., & Day, C. P. (2005) · Gut · doi:10.1136/gut.2004.057968 · Cited by 219
Self-citation
Vascular adhesion protein-1 promotes liver inflammation and drives hepatic fibrosis
Weston, C. J., Shepherd, E. L., Claridge, L. C., Rantakari, P., Curbishley, S. M., Tomlinson, J., Hübscher, S. G., Reynolds, G. M., Aalto, K., Anstee, Q. M., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci73722 · Cited by 214
Treating Atherosclerosis With Regulatory T Cells
Foks, A. C., Lichtman, A. H., & Kuiper, J. (2014) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.114.303568 · Cited by 203
A high-fat diet and regulatory T cells influence susceptibility to endotoxin-induced liver injury
Ma, X., Hua, J., Mohamood, A. R., Hamad, A. R. A., Ravi, R. K., & Li, Z. (2007) · Hepatology · doi:10.1002/hep.21823 · Cited by 199
The microbiota maintain homeostasis of liver-resident γδT-17 cells in a lipid antigen/CD1d-dependent manner
Li, F., Hao, X., Chen, Y., Bai, L., Gao, X., Lian, Z., Wei, H., Sun, R., & Tian, Z. (2017) · Nature Communications · doi:10.1038/ncomms13839 · Cited by 191
Type I Interferon Responses Drive Intrahepatic T Cells to Promote Metabolic Syndrome
Ghazarian, M., Revelo, X. S., Nøhr, M. K., Luck, H., Zeng, K., Lei, H., Tsai, S., Schroer, S. A., Park, Y. J., Chng, M. H. Y., et al. (2017) · Science Immunology · doi:10.1126/sciimmunol.aai7616 · Cited by 190
Dendritic Cells Limit Fibroinflammatory Injury in Nonalcoholic Steatohepatitis in Mice
Henning, J. R., Graffeo, C. S., Rehman, A., Fallon, N. C., Zambirinis, C. P., Ochi, A., Barilla, R., Jamal, M., Deutsch, M., Greco, S., et al. (2013) · Hepatology · doi:10.1002/hep.26267 · Cited by 185
Dendritic Cell Populations With Different Concentrations of Lipid Regulate Tolerance and Immunity in Mouse and Human Liver
Ibrahim, J., Nguyen, A. H., Rehman, A. U., Ochi, A., Jamal, M., Graffeo, C. S., Henning, J. R., Zambirinis, C. P., Fallon, N. C., Barilla, R., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.06.003 · Cited by 182
The innate immune response to products of phospholipid peroxidation
Weismann, D., & Binder, C. J. (2012) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2012.01.018 · Cited by 174
IL-15 Regulates Homeostasis and Terminal Maturation of NKT Cells
Gordy, L. E., Bezbradica, J. S., Flyak, A. I., Spencer, C. T., Dunkle, A. D., Sun, J., Stanic, A. K., Boothby, M. R., He, Y.-W., Zhao, Z., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003965 · Cited by 170
Intestinal Microbiota and Nonalcoholic Steatohepatitis
Brandl, K., & Schnabl, B. (2017) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000349 · Cited by 169
Nonalcoholic Fatty Liver Disease in Children
Mann, J. P., Valenti, L. V. C., Scorletti, E., Byrne, C. D., & Nobili, V. (2018) · Seminars in Liver Disease · doi:10.1055/s-0038-1627456 · Cited by 169
Should we undertake surveillance for HCC in patients with NAFLD?
Younes, R., & Bugianesi, E. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2017.10.006 · Cited by 165
Kupffer Cell and Interleukin-12–Dependent Loss of Natural Killer T Cells in Hepatosteatosis
Kremer, M., Thomas, E., Milton, R. J., Perry, A. W., van Rooijen, N., Wheeler, M. D., Zacks, S., Fried, M., Rippe, R. A., & Hines, I. N. (2009) · Hepatology · doi:10.1002/hep.23292 · Cited by 164
Detection of circulating antibodies against malondialdehyde-acetaldehyde adducts in patients with alcohol-induced liver disease
Rolla, R., Vay, D., Mottaran, E., Parodi, M., Traverso, N., Aricò, S., Sartori, M., Bellomo, G., Klassen, L. W., Thiele, G. M., et al. (2000) · Hepatology · doi:10.1053/he.2000.5373 · Cited by 163
Self-citation
The balance between IL-17 and IL-22 produced by liver-infiltrating T-helper cells critically controls NASH development in mice
Rolla, S., Alchera, E., Imarisio, C., Bardina, V., Valente, G., Cappello, P., Mombello, C., Follenzi, A., Novelli, F., & Carini, R. (2016) · Clinical Science · doi:10.1042/cs20150405 · Cited by 158
Hepatic natural killer T‐cell and CD8+ T‐cell signatures in mice with nonalcoholic steatohepatitis
Bhattacharjee, J., Kirby, M., Softic, S., Miles, L., Salazar‐Gonzalez, R., Shivakumar, P., & Kohli, R. (2017) · Hepatology Communications · doi:10.1002/hep4.1041 · Cited by 146
NKp46(+) natural killer cells attenuate metabolism-induced hepatic fibrosis by regulating macrophage activation in mice
Tosello‐Trampont, A., Krueger, P., Narayanan, S., Landes, S. G., Leitinger, N., & Hahn, Y. S. (2016) · Hepatology · doi:10.1002/hep.28389 · Cited by 142
B2-Lymphocyte Responses to Oxidative Stress-Derived Antigens Contribute to the Evolution of Nonalcoholic Fatty Liver Disease (NAFLD)
Bruzzì, S., Sutti, S., Giudici, G., Burlone, M. E., Ramavath, N. N., Toscani, A., Bozzola, C., Schneider, P., Morello, E., Parola, M., et al. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.06.015 · Cited by 139
Self-citation
OX40: Structure and function – What questions remain?
Willoughby, J. E., Griffiths, J., Tews, I., & Cragg, M. S. (2017) · Molecular Immunology · doi:10.1016/j.molimm.2017.01.006 · Cited by 137
Lipid oxidation products in the pathogenesis of non-alcoholic steatohepatitis
Bellanti, F., Villani, R., Facciorusso, A., Vendemiale, G., & Serviddio, G. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.01.023 · Cited by 136
Immunoregulatory Role of NK Cells in Tissue Inflammation and Regeneration
Tosello-Trampont, A., Surette, F. A., Ewald, S. E., & Hahn, Y. S. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00301 · Cited by 134
Protective Role for B-1b B Cells and IgM in Obesity-Associated Inflammation, Glucose Intolerance, and Insulin Resistance
Harmon, D. B., Srikakulapu, P., Kaplan, J. L., Oldham, S. N., McSkimming, C. C., Garmey, J. C., Perry, H. M., Kirby, J. L., Prohaska, T. A., Gonen, A., et al. (2016) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.116.307166 · Cited by 126
Serum Immunoglobulin Levels Predict Fibrosis in Patients With Non-Alcoholic Fatty Liver Disease
McPherson, S., Henderson, E., Burt, A. D., Day, C. P., & Anstee, Q. M. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.01.010 · Cited by 124
Role of liver-infiltrating CD3+CD56+ natural killer T cells in the pathogenesis of nonalcoholic fatty liver disease
Tajiri, K., Shimizu, Y., Tsuneyama, K., & Sugiyama, T. (2009) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e32831bc3d6 · Cited by 122
IFN-γ Deficiency Attenuates Hepatic Inflammation and Fibrosis in a Steatohepatitis Model Induced by a Methionine- and Choline-Deficient High-Fat Diet
Luo, X.-Y., Takahara, T., Kawai, K., Fujino, M., Sugiyama, T., Tsuneyama, K., Tsukada, K., Nakae, S., Zhong, L., & Li, X.-K. (2013) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00193.2013 · Cited by 120
Increasing numbers of hepatic dendritic cells promote HMGB1-mediated ischemia-reperfusion injury
Tsung, A., Zheng, N., Jeyabalan, G., Izuishi, K., Klune, J. R., Geller, D. A., Lotze, M. T., Lü, L., & Billiar, T. R. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.0706468 · Cited by 118
Targeting B Cells in Atherosclerosis
Tsiantoulas, D., Sage, A. P., Mallat, Z., & Binder, C. J. (2014) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.114.303569 · Cited by 118
Vascular Adhesion Protein-1: A Cell Surface Amine Oxidase in Translation
Salmi, M., & Jalkanen, S. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7418 · Cited by 117
Regulation of Inflammation by IL-17A and IL-17F Modulates Non-Alcoholic Fatty Liver Disease Pathogenesis
Giles, D. A., Moreno-Fernandez, M. E., Stankiewicz, T. E., Cappelletti, M., Huppert, S. S., Iwakura, Y., Dong, C., Shanmukhappa, S. K., & Divanovic, S. (2016) · PLOS ONE · doi:10.1371/journal.pone.0149783 · Cited by 116
Altered Phenotype and Functionality of Circulating Immune Cells Characterize Adult Patients With Nonalcoholic Steatohepatitis
Inzaugarat, M. E., Ferreyra Solari, N. E., Billordo, L. A., Abecasis, R., Gadano, A. C., & Cherñavsky, A. C. (2011) · Journal of Clinical Immunology · doi:10.1007/s10875-011-9571-1 · Cited by 115
CX3CR1 is a gatekeeper for intestinal barrier integrity in mice: Limiting steatohepatitis by maintaining intestinal homeostasis
Schneider, K. M., Bieghs, V., Heymann, F., Hu, W., Yildiz, D., Liao, L., Frissen, M., Ludwig, A., Gaßler, N., Pabst, O., et al. (2015) · Hepatology · doi:10.1002/hep.27982 · Cited by 112
Malondialdehyde Epitopes as Targets of Immunity and the Implications for Atherosclerosis
Papac-Miličević, N., Busch, C. J., & Binder, C. J. (2016) · Advances in immunology · doi:10.1016/bs.ai.2016.02.001 · Cited by 112
Immune Cell Crosstalk in Obesity: A Key Role for Costimulation?
Seijkens, T. T. P., Kusters, P. J. H., Chatzigeorgiou, A., Chavakis, T., & Lutgens, E. (2014) · Diabetes · doi:10.2337/db14-0272 · Cited by 108
Mucosal-associated invariant T cells improve nonalcoholic fatty liver disease through regulating macrophage polarization
Li, Y., Huang, B., Jiang, X., Chen, W., Zhang, J., Wei, Y., Chen, Y., Lian, M., Bian, Z., Miao, Q., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01994 · Cited by 107
Endogenous annexin A1 is a novel protective determinant in nonalcoholic steatohepatitis in mice
Locatelli, I., Sutti, S., Jindal, A., Vacchiano, M., Bozzola, C., Reutelingsperger, C. P. M., Kusters, D. H. M., Bena, S., Parola, M., Paternostro, C., et al. (2014) · Hepatology · doi:10.1002/hep.27141 · Cited by 106
Self-citation
Liver Fibrosis Occurs Through Dysregulation of MyD88-Dependent Innate B-Cell Activity
Thapa, M., Chinnadurai, R., Velazquez, V. M., Tedesco, D., Elrod, E., Han, J., Sharma, P., Ibegbu, C., Gewirtz, A., Anania, F., et al. (2015) · Hepatology · doi:10.1002/hep.27761 · Cited by 101
N-Acetylcysteine Attenuates Progression of Liver Pathology in a Rat Model of Nonalcoholic Steatohepatitis3
Baumgardner, J. N., Shankar, K., Hennings, L. J., Albano, E., Badger, T. M., & Ronis, M. J. J. (2008) · Journal of Nutrition · doi:10.1093/jn/138.10.1872 · Cited by 100
Self-citation
Specific immunization strategies against oxidized low-density lipoprotein: A novel way to reduce nonalcoholic steatohepatitis in mice
Bieghs, V., van Gorp, P. J., Walenbergh, S. M. A., Gijbels, M. J., Verheyen, F., Buurman, W. A., Briles, D. E., Hofker, M. H., Binder, C. J., & Shiri‐Sverdlov, R. (2012) · Hepatology · doi:10.1002/hep.25660 · Cited by 98
HCC Development Is Associated to Peripheral Insulin Resistance in a Mouse Model of NASH
De Minicis, S., Agostinelli, L., Rychlicki, C., Sorice, G. P., Saccomanno, S., Candelaresi, C., Giaccari, A., Trozzi, L., Pierantonelli, I., Mingarelli, E., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0097136 · Cited by 97
Murine CD103+ dendritic cells protect against steatosis progression towards steatohepatitis
Heier, E.-C., Meier, A., Julich-Haertel, H., Djudjaj, S., Rau, M., Tschernig, T., Geier, A., Boor, P., Lammert, F., & Lukacs-Kornek, V. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.01.008 · Cited by 94
Oxidative stress parameters in paediatric non-alcoholic fatty liver disease
Nobili, V. (2010) · International Journal of Molecular Medicine · doi:10.3892/ijmm_00000487 · Cited by 93
Depletion of B cells induces remission of autoimmune hepatitis in mice through reduced antigen presentation and help to T cells
Béland, K., Marceau, G., Labardy, A., Bourbonnais, S., & Alvarez, F. (2015) · Hepatology · doi:10.1002/hep.27991 · Cited by 93
Differential Activation of Hepatic Invariant NKT Cell Subsets Plays a Key Role in Progression of Nonalcoholic Steatohepatitis
Maricic, I., Marrero, I., Eguchi, A., Nakamura, R., Johnson, C. D., Dasgupta, S., Hernandez, C. D., Nguyen, P. S., Swafford, A. D., Knight, R., et al. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1800614 · Cited by 92
The Complex Myeloid Network of the Liver with Diverse Functional Capacity at Steady State and in Inflammation
Eckert, C., Klein, N., Kornek, M., & Kornek, M. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00179 · Cited by 84
CX3CR1-expressing inflammatory dendritic cells contribute to the progression of steatohepatitis
Sutti, S., Locatelli, I., Bruzzì, S., Jindal, A., Vacchiano, M., Bozzola, C., & Albano, E. (2015) · Clinical Science · doi:10.1042/cs20150053 · Cited by 83
Self-citation
Tim-3/Galectin-9 Regulate the Homeostasis of Hepatic NKT Cells in a Murine Model of Nonalcoholic Fatty Liver Disease
Tang, Z.-H., Liang, S., Potter, J. J., Jiang, X., Mao, H., & Li, Z. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202814 · Cited by 80
Interleukin-15-mediated inflammation promotes non-alcoholic fatty liver disease
Donates, Y. C., Lacraz, G., Ghobadi, F., Rakotoarivelo, V., Orkhis, S., Mayhue, M., Chen, Y.-G., Rola‐Pleszczynski, M., Menéndez, A., Ilangumaran, S., et al. (2016) · Cytokine · doi:10.1016/j.cyto.2016.01.020 · Cited by 79
Disruption of adenosine 2A receptor exacerbates NAFLD through increasing inflammatory responses and SREBP1c activity
Cai, Y., Li, H., Liu, M., Pei, Y., Zheng, J., Zhou, J., Luo, X., Huang, W., Ma, L., Yang, Q., et al. (2018) · Hepatology · doi:10.1002/hep.29777 · Cited by 79
The Role of Innate Cells Is Coupled to a Th1-Polarized Immune Response in Pediatric Nonalcoholic Steatohepatitis
Solari, N. E. F., Inzaugarat, M. E., Baz, P., Matteo, E. D., Lezama, C., Galoppo, M., Galoppo, C., & Cherñavsky, A. C. (2012) · Journal of Clinical Immunology · doi:10.1007/s10875-011-9635-2 · Cited by 78
Role of Regulatory Cells in Oral Tolerance
Wawrzyniak, M., O’Mahony, L., & Akdiş, M. (2017) · Allergy Asthma and Immunology Research · doi:10.4168/aair.2017.9.2.107 · Cited by 78
Sialic Acid-Binding Immunoglobulin-like Lectin G Promotes Atherosclerosis and Liver Inflammation by Suppressing the Protective Functions of B-1 Cells
Gruber, S., Hendrikx, T., Tsiantoulas, D., Ozsvár-Kozma, M., Göderle, L., Mallat, Z., Witztum, J. L., Shiri‐Sverdlov, R., Nitschke, L., & Binder, C. J. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.02.027 · Cited by 75
Dual role of B7 costimulation in obesity-related nonalcoholic steatohepatitis and metabolic dysregulation
Chatzigeorgiou, A., Chung, K., García-Martín, R., Alexaki, V. I., Ameln, A. K., Phieler, J., Sprott, D., Kanczkowski, W., Tzanavari, T., Bdeir, M., et al. (2014) · Hepatology · doi:10.1002/hep.27233 · Cited by 73
Dendritic cells and liver fibrosis
Rahman, A. H., & Aloman, C. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.01.005 · Cited by 73
Natural Killer Cells and Type 1 Innate Lymphoid Cells Are New Actors in Non-alcoholic Fatty Liver Disease
Luci, C., Vieira, E., Perchet, T., Gual, P., & Golub, R. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01192 · Cited by 73
Alleviation of insulin resistance and liver damage by oral administration of Imm124-E is mediated by increased Tregs and associated with increased serum GLP-1 and adiponectin: results of a phase I/II clinical trial in NASH
Yaʼacov, A. B., Mizrahi, M., Shabat, Y., Lalazar, G., Adar, T., Wong, V., Muller, B. D., Rawlin, G., & Ilan (2012) · Journal of Inflammation Research · doi:10.2147/jir.s35227 · Cited by 71
Oral administration of immunoglobulin G-enhanced colostrum alleviates insulin resistance and liver injury and is associated with alterations in natural killer T cells
Adar, T., Yaʼacov, A. B., Lalazar, G., Lichtenstein, Y., Nahman, D., Mizrahi, M., Wong, V., Muller, B. D., Rawlin, G., & Ilan, Y. (2011) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2011.04511.x · Cited by 69
Malondialdehyde epitopes are sterile mediators of hepatic inflammation in hypercholesterolemic mice
Busch, C. J., Hendrikx, T., Weismann, D., Jäckel, S., Walenbergh, S. M. A., Rendeiro, A. F., Weißer, J., Puhm, F., Hladik, A., Göderle, L., et al. (2016) · Hepatology · doi:10.1002/hep.28970 · Cited by 69
NF-κB1 deficiency stimulates the progression of non-alcoholic steatohepatitis (NASH) in mice by promoting NKT-cell-mediated responses
Locatelli, I., Sutti, S., Vacchiano, M., Bozzola, C., & Albano, E. (2012) · Clinical Science · doi:10.1042/cs20120289 · Cited by 68
Self-citation
Macrophages in nonalcoholic fatty liver disease: a role model of pathogenic immunometabolism
Krenkel, O., & Tacke, F. (2017) · Seminars in Liver Disease · doi:10.1055/s-0037-1604480 · Cited by 66
Microvesicles released from fat-laden cells promote activation of hepatocellular NLRP3 inflammasome: A pro-inflammatory link between lipotoxicity and non-alcoholic steatohepatitis
Cannito, S., Morello, E., Bocca, C., Foglia, B., Benetti, E., Novo, E., Chiazza, F., Rogazzo, M., Fantozzi, R., Povero, D., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0172575 · Cited by 65
Self-citation
B-lymphocyte effector functions in health and disease
DiLillo, D. J., Horikawa, M., & Tedder, T. F. (2010) · Immunologic Research · doi:10.1007/s12026-010-8189-3 · Cited by 61
B Cell-Activating Factor is Associated With the Histological Severity of Nonalcoholic Fatty Liver Disease
Miyake, T., Abe, M., Tokumoto, Y., Hirooka, M., Furukawa, S., Kumagi, T., Hamada, M., Kawasaki, K., Tada, F., Ueda, T., et al. (2013) · Hepatology International · doi:10.1007/s12072-012-9345-8 · Cited by 59
Type 3 innate lymphoid cell: a new player in liver fibrosis progression
Wang, S., Li, J., Wu, S., Cheng, L.-S., Shen, Y. L., Ma, W., She, W., Yang, C., Wang, J., & Jiang, W. (2018) · Clinical Science · doi:10.1042/cs20180482 · Cited by 59
Complex Network of NKT Cell Subsets Controls Immune Homeostasis in Liver and Gut
Marrero, I., Maricic, I., Feldstein, A. E., Loomba, R. S., Schnabl, B., Rivera–Nieves, J., Eckmann, L., & Kumar, V. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02082 · Cited by 55
Amelioration of non‐alcoholic steatohepatitis and glucose intolerance in ob/ob mice by oral immune regulation towards liver‐extracted proteins is associated with elevated intrahepatic NKT lymphocytes and serum IL‐10 levels
Elinav, E., Pappo, O., Sklair‐Levy, M., Margalit, M., Shibolet, O., Gomori, M. J., Alper, R., Thalenfeld, B. E., Engelhardt, D., Rabbani, E., et al. (2005) · The Journal of Pathology · doi:10.1002/path.1869 · Cited by 48
OX40 Regulates Both Innate and Adaptive Immunity and Promotes Nonalcoholic Steatohepatitis.
Sun, G.-Y., Jin, H., Zhang, C.-P., Meng, H., Zhao, X.-Y., Wei, D., Ou, X.-J., Wang, Q.-Y., Li, S.-X., Wang, T., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.12.006 · Cited by 48
Immunotherapy with oral administration of humanized anti-CD3 monoclonal antibody: a novel gut-immune system-based therapy for metaflammation and NASH
Ilan, Y., Shailubhai, K., & Sanyal, A. J. (2018) · Clinical & Experimental Immunology · doi:10.1111/cei.13159 · Cited by 46
γδ T cells in liver diseases
Wang, X., & Tian, Z. (2018) · Frontiers of Medicine · doi:10.1007/s11684-017-0584-x · Cited by 43
Mesenteric lymph node CD4+ T lymphocytes migrate to liver and contribute to non-alcoholic fatty liver disease
Su, L. C., Wu, Z., Chi, Y., Song, Y., Xu, J., Tan, J., Xu, C., & Liu, Y. (2019) · Cellular Immunology · doi:10.1016/j.cellimm.2019.01.005 · Cited by 43
Type 3 cytokines in liver fibrosis and liver cancer
Molina, M. F., Abdelnabi, M. N., Fabre, T., & Shoukry, N. H. (2018) · Cytokine · doi:10.1016/j.cyto.2018.07.028 · Cited by 41
Genetic inactivation of the LIGHT (TNFSF14) cytokine in mice restores glucose homeostasis and diminishes hepatic steatosis
Herrero-Cervera, A., Vinué, Á., Burks, D. J., & Navarro, H. G. (2019) · Diabetologia · doi:10.1007/s00125-019-4962-6 · Cited by 41
Mesenteric adipose tissue B lymphocytes promote local and hepatic inflammation in non‐alcoholic fatty liver disease mice
Wu, Z., Xu, J., Tan, J., Song, Y., Liu, L., Zhang, F., Zhang, Y., Li, X., Chi, Y., & Liu, Y. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14232 · Cited by 38
ATVB Distinguished Scientist Award
Ley, K. F., Gerdes, N., & Winkels, H. (2017) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.117.308611 · Cited by 37
Low levels of IgM antibodies recognizing oxidation-specific epitopes are associated with human non-alcoholic fatty liver disease
Hendrikx, T., Watzenböck, M. L., Walenbergh, S. M. A., Amir, S., Gruber, S., Kozma, M. O., Grabsch, H. I., Koek, G. H., Pierik, M. J., Staufer, K., et al. (2016) · BMC Medicine · doi:10.1186/s12916-016-0652-0 · Cited by 32
OX40 promotes obesity-induced adipose inflammation and insulin resistance
Liu, B., Yu, H., Sun, G., Sun, X., Jin, H., Zhang, C., Shi, W., Tian, D., Liu, K., Xu, H., et al. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2552-7 · Cited by 30

Sorted by citations

Hepatocellular carcinoma
Llovet, J. M., Kelley, R. K., Villanueva, A., Singal, A. G., Pikarsky, E., Roayaie, S., Lencioni, R., Koike, K., Zucman-Rossi, J., & Finn, R. S. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-00240-3 · Cited by 7,055
Hepatic inflammatory responses in liver fibrosis
Hammerich, L., & Tacke, F. (2023) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-023-00807-x · Cited by 803
The immunological and metabolic landscape in primary and metastatic liver cancer
Li, X., Ramadori, P., Pfister, D. R., Seehawer, M., Zender, L., & Heikenwälder, M. F. (2021) · Nature reviews. Cancer · doi:10.1038/s41568-021-00383-9 · Cited by 639
Immune mechanisms linking metabolic injury to inflammation and fibrosis in fatty liver disease – novel insights into cellular communication circuits
Peiseler, M., Schwabe, R., Hampe, J., Kubes, P., Heikenwälder, M., & Tacke, F. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.06.012 · Cited by 564
Non-alcoholic fatty liver disease: the interplay between metabolism, microbes and immunity
Tilg, H., Adolph, T. E., Dudek, M., & Knolle, P. A. (2021) · Nature Metabolism · doi:10.1038/s42255-021-00501-9 · Cited by 539

See all 386

Authors: Sutti, S., & Albano, E.
Affiliations: Università degli Studi del Piemonte Orientale “Amedeo Avogadro” (IT)
Corresponding author: Albano, Emanuele
ORCID: Sutti, Salvatore
Albano, Emanuele
Venue: Nature Reviews Gastroenterology & Hepatology
Publisher: Springer Science and Business Media LLC
Published: 2019-10-11
Volume: 17
Issue: 2
Pages: 81-92
ISSN: 1759-5045 (ISSN-L)
1759-5053
DOI: 10.1038/s41575-019-0210-2
PMC: PMC7222953
OpenAlex: W2979371456
Cited by: 374
References: 137
Citations by year: 2026: 35 · 2025: 42 · 2024: 67 · 2023: 70 · 2022: 75 · 2021: 55 · 2020: 27 · 2019: 1
FWCI: 5.94
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.springernature.com/gp/researchers/text-and-data-mining (tdm)
www.springernature.com/gp/researchers/text-and-data-mining (vor)
Locations: Nature Reviews Gastroenterology & Hepatology (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: Fondazione Cariplo (2011-0470)
Ministero dell’Istruzione, dell’Università e della Ricerca (FAR 2015)
Topics: Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
Health Sciences › Medicine › Hepatology › Liver physiology and pathology
Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
Keywords: non-alcoholic fatty liver disease, nonalcoholic steatohepatitis, adaptive immunity, B cells, T cells, liver inflammation, liver fibrosis, hepatocellular carcinoma, immune tolerance, immunomodulatory therapy, disease progression
MeSH terms: B-Lymphocytes, Carcinoma, Hepatocellular, Humans, Immune Tolerance, Immunity, Innate, Liver Cirrhosis, Liver Neoplasms, T-Lymphocytes, Oxidative Stress, Disease Progression, Natural Killer T-Cells, Adaptive Immunity, Non-alcoholic Fatty Liver Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Adaptive immunity: an emerging player in the progression of NAFLD

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks